| Pharmaceutical active ingredients: |
| Lanreotide |
| Available forms, composition and doses of Angiopeptin: |
| N / A |
| Angiopeptin medical category: |
| Human:Somatostatin analogues |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| H01CB03 - Lanreotide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Anginal | Dipyridamole | Unidentified Pharmaceutical Company |
| Anginyl | Diltiazem | Unidentified Pharmaceutical Company |
| Angioamin | Xantinol Nicotinate | Unidentified Pharmaceutical Company |
| Angiokapsul | Clofibrate | Unidentified Pharmaceutical Company |
| Angiomin | Xantinol Nicotinate | Unidentified Pharmaceutical Company |
| Angioton | Pentetrazol | Unidentified Pharmaceutical Company |
| Angiotonin | Pentetrazol | Unidentified Pharmaceutical Company |
| Angitet | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Angonist | Nitroglycerin | Unidentified Pharmaceutical Company |
| Angorin | Nitroglycerin | Unidentified Pharmaceutical Company |